CLINICAL_TRIALS
trial_result
· 2022-09-07
Clinical Trial Update: A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients [Phase 3]
Summary
Phase 3 trial comparing LY2140023 with aripiprazole in schizophrenia was terminated; results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Denovo Biopharma LLC | Conditions: Schizophrenia | Phase 3 | Status: TERMINATED | Results posted: 2022-09-07